Anzeige
Mehr »
Login
Dienstag, 05.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
300% Aktienanstieg war nur der Vorgeschmack – Warum diese Kupferstory noch besser wird!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
443 Leser
Artikel bewerten:
(2)

Pensana Plc - Grant of Share Awards

Pensana Plc - Grant of Share Awards

PR Newswire

17 May 2022

Pensana Plc

("Pensana"or the"Company")

Grant of Share Awards

Pensana Plc, announces that, on 16 May 2022, it granted share awards over, in aggregate, 2,179,619 ordinary shares of 1p each in the capital of the Company ("Ordinary Shares") to directors, senior management and employees. For the purposes of the allocation, a share price of 120p per Ordinary Share was used.

Accordingly, a total of 4,429,619 share awards are outstanding following these latest grants, which represents approximately 1.88 per cent of the Company's existing issued share capital of 235,599,539 Ordinary Shares.

Executive Directors

The following new Share Awards have been granted to Executive Directors and/or Officers of the Company:

NamePositionNumber of New Share Awards GrantedVesting PeriodTotal Share Awards Held Following This Grant
Tim GeorgeCEO708,3333 years1,958,333
Robert KaplanCFO487,5003 years1,487,500
Rocky SmithCOO400,0003 years400,000

The new Share Awards set out in the table above for Executive Directors and/or Officers all vest in one tranche (three years from the date of grant) subject to the satisfaction of certain performance conditions to be determined and interpreted at the discretion of the Remuneration Committee over the three-year period. Upon vesting, no consideration is payable. Subject to vesting and such performance conditions being met, the new Share Awards will be allocated to the participant as fully paid ordinary shares.


Senior Management and Employees

A further 583,785 Share Awards, in aggregate, have been granted to certain other members of senior management and employees. For the purposes of the allocation, a share price of 120p per Ordinary Share was used.

The notifications below are made in accordance with the requirements of MAR.

PDMR Notification Forms

1Details of the person discharging managerial responsibilities/person closely associated
a)NameTim George
2Reason for the notification
a)Position/statusCEO
b)Initial notification/AmendmentInitial notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NamePensana Plc
b)LEI213800H4QP6T9499RU64
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrumentOrdinary shares of 1p each
Identification codeGB00BKM0ZJ18
b)Nature of the transactionGrant of Share Awards
c)Price(s) and volume(s)Price: N/A
Volume: 708,333
d)Aggregated informationAggregated volume: N/A
Price: N/A
e)Date of the transaction16 May 2022
f)Place of the transactionLSE

1Details of the person discharging managerial responsibilities/person closely associated
a)NameRobert Kaplan
2Reason for the notification
a)Position/statusCFO
b)Initial notification/AmendmentInitial notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NamePensana Plc
b)LEI213800H4QP6T9499RU64
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrumentOrdinary shares of 1p each
Identification codeGB00BKM0ZJ18
b)Nature of the transactionGrant of Share Awards
c)Price(s) and volume(s)Price: N/A
Volume: 487,500
d)Aggregated informationAggregated volume: N/A
Price: N/A
e)Date of the transaction16 May 2022
f)Place of the transactionLSE

1Details of the person discharging managerial responsibilities/person closely associated
a)NameRocky Smith
2Reason for the notification
a)Position/statusCOO
b)Initial notification/AmendmentInitial notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NamePensana Plc
b)LEI213800H4QP6T9499RU64
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrumentOrdinary shares of 1p each
Identification codeGB00BKM0ZJ18
b)Nature of the transactionGrant of Share Awards
c)Price(s) and volume(s)Price: N/A
Volume: 400,000
d)Aggregated informationAggregated volume: N/A
Price: N/A
e)Date of the transaction16 May 2022
f)Place of the transactionLSE

ENDS

For further information, please contact:

Shareholder/analyst enquiries:

Pensana Plc

Paul Atherley, Chairman IR@pensana.co.uk

Tim George, Chief Executive Officer

Virginia Skroski, Head of Investor Relations & Communications

Media enquiries:

Finsbury Glover Hering:

Gordon Simpson / Richard Crowley Pensana-LON@finsbury.com

About Pensana plc

The electrification of motive power is the most important part of the energy transition and one of the biggest energy transitions in history. Magnet metals are central to the transition and critical to high value manufacturing applications such as electric vehicles and offshore wind turbines.

Pensana plans to establish Saltend as an independent, sustainable supplier of the key magnet metal oxides to a market which is currently dominated by China. The US$190 million Saltend facility is being designed to produce circa 12,500 tonnes per annum of rare earth oxides, of which 4,500 tonnes will be neodymium and praseodymium (NdPr), representing over 5% of the world market in 2025.

The Saltend facility is located within the world class Saltend Chemicals Park, a cluster of leading chemicals and renewable energy businesses at the heart of the UK's energy estuary, and host to a range of companies including BP Petrochemicals technology, INEOS, Air Products, Triton Power, Nippon Gohsei and Tricoya.

Pensana's plug and play facility will create over 500 jobs during construction and over 125 direct jobs once in production. It will be the first major separation facility to be established in over a decade and will become one of only three major producers located outside China.

Initial feedstock will be shipped as a clean, high purity mixed rare earth sulphate (MRES) from the Company's Longonjo low impact mine in Angola. The mine's state-of-the-art concentrator and proprietary MRES processing plant are being designed by Wood to the highest international standards. They will be powered by minimal carbon hydro-electric power and connected to the Port of Lobito by the recently upgraded Benguela railway line.

Pensana is of the view that provenance of critical rare earth materials supply, life cycle analysis and GHG Scope 1, 2 and 3 emissions will all become significant factors in supply chains for major customers. The Company intends to offer customers an independently and sustainably sourced supply of the metal oxides and carbonates of increasing importance to a range of applications central to the energy transition, industrial, medical, military and communications sectors.

For many miners around the world who are looking to access the European and US supply chains, it is becoming increasingly clear that the proposed EU and possible UK carbon border taxation would mean that it is no longer acceptable for manufacturers to source material extracted or processed unsustainably.

Pensana is aiming to establish Saltend as an attractive alternative to mining houses who may otherwise be limited to selling their products to China, having designed the facility to be easily adapted to cater for a range of rare earth feedstocks.

www.pensana.co.uk

© 2022 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.